Bruce W.S. Robinson, Allan James, Alison H. Rose, Gregory F. Sterrett, Arthur W. Musk
{"title":"Bronchoalveolar lavage sampling of airway and alveolar cells","authors":"Bruce W.S. Robinson, Allan James, Alison H. Rose, Gregory F. Sterrett, Arthur W. Musk","doi":"10.1016/0007-0971(88)90007-1","DOIUrl":null,"url":null,"abstract":"<div><p>Bronchoalveolar lavage (BAL) cell counts are used to assess ‘alveolitis’ in patients with interstitial lung diseases (ILD) but inflammatory cells from airways can contribute to the differential cell count. To determine what BAL volume samples airway cells in patients with ILD we measured the proportion of bronchial epithelial cells (BECs) in four successive 25 ml aliquots in a single lung subsegment in 23 patients with ILD (cryptogenic fibrosing alveolitis (CFA) four, rheumatoid lung (RL) three, asbestosis (ASB) 11, sarcoidosis (SARC) five). Cells recovered from the first two 25 ml lavages exhibited higher proportions of BECs (15±14% and 9±2% respectively) than those from the rermaining two aliquots (3±1%, 3±1%, each <em>P</em><0.01), suggesting that the first 50 ml BAL preferentially sampled airway cells compared to the second 50 ml BAL. To evaluate airway and alveolar inflammatory cell proportions in ILD we performed two separate 50 ml BALs (samples I and II) in a single subsegment in 38 patients with ILD (CFA seven, RL five, ASB 19, SARC seven) and measured the proportions of recovered cells in each sample separately and combined. Seven control individuals were also studied. Sample I contained 1–67% (mean 26±3%) of the total recovered cells. Neutrophil (PMN) proportions were higher in sample I compared to sample II in CFA (20±6 vs 8±2%), RL (30±9 vs 8±2%) and ASB (12±2 vs 7±1%), <em>P</em><0.05 for each, but were similar in samples I and II in patients with SARC (3±1 vs 2±1%) and controls (2±1 vs 2±1%). In combined samples (I+II), absolute PMN proportions were up to 8% higher than in sample II alone whereas absolute lymphocyte proportions were up to 8% less than in sample II alone. These data suggest that separate processing of the fluid recovered from the first 50 ml BAL in ILD patients provides information on the location of inflammatory cells and improves the accuracy of BAL cell counts.</p></div>","PeriodicalId":75618,"journal":{"name":"British journal of diseases of the chest","volume":"82 ","pages":"Pages 45-55"},"PeriodicalIF":0.0000,"publicationDate":"1988-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0007-0971(88)90007-1","citationCount":"19","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"British journal of diseases of the chest","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/0007097188900071","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 19
Abstract
Bronchoalveolar lavage (BAL) cell counts are used to assess ‘alveolitis’ in patients with interstitial lung diseases (ILD) but inflammatory cells from airways can contribute to the differential cell count. To determine what BAL volume samples airway cells in patients with ILD we measured the proportion of bronchial epithelial cells (BECs) in four successive 25 ml aliquots in a single lung subsegment in 23 patients with ILD (cryptogenic fibrosing alveolitis (CFA) four, rheumatoid lung (RL) three, asbestosis (ASB) 11, sarcoidosis (SARC) five). Cells recovered from the first two 25 ml lavages exhibited higher proportions of BECs (15±14% and 9±2% respectively) than those from the rermaining two aliquots (3±1%, 3±1%, each P<0.01), suggesting that the first 50 ml BAL preferentially sampled airway cells compared to the second 50 ml BAL. To evaluate airway and alveolar inflammatory cell proportions in ILD we performed two separate 50 ml BALs (samples I and II) in a single subsegment in 38 patients with ILD (CFA seven, RL five, ASB 19, SARC seven) and measured the proportions of recovered cells in each sample separately and combined. Seven control individuals were also studied. Sample I contained 1–67% (mean 26±3%) of the total recovered cells. Neutrophil (PMN) proportions were higher in sample I compared to sample II in CFA (20±6 vs 8±2%), RL (30±9 vs 8±2%) and ASB (12±2 vs 7±1%), P<0.05 for each, but were similar in samples I and II in patients with SARC (3±1 vs 2±1%) and controls (2±1 vs 2±1%). In combined samples (I+II), absolute PMN proportions were up to 8% higher than in sample II alone whereas absolute lymphocyte proportions were up to 8% less than in sample II alone. These data suggest that separate processing of the fluid recovered from the first 50 ml BAL in ILD patients provides information on the location of inflammatory cells and improves the accuracy of BAL cell counts.
支气管肺泡灌洗(BAL)细胞计数用于评估间质性肺疾病(ILD)患者的“肺泡炎”,但来自气道的炎症细胞可导致细胞计数的差异。为了确定BAL体积对ILD患者气道细胞的采样,我们测量了23例ILD患者(隐源性纤维化肺泡炎(CFA) 4例,类风湿性肺(RL) 3例,石棉肺(ASB) 11例,结节病(SARC) 5例)单个肺亚段中连续4个25 ml等分中支气管上皮细胞(BECs)的比例。前两次25 ml灌洗液中回收的细胞BECs比例(分别为15±14%和9±2%)高于其余两次灌洗液(3±1%,3±1%,每个P<0.01),表明第一次50 ml BAL比第二次50 ml BAL更优先取样气道细胞。为了评估ILD患者气道和肺泡炎症细胞的比例,我们在38例ILD患者(CFA 7例,RL 5例,ASB 19例,SARC 7例)的单个亚段中分别进行了两次50 ml bal(样本I和样本II),并分别测量了每个样本中回收细胞的比例。还研究了7个对照个体。样品1含总回收细胞的1-67%(平均26±3%)。中性粒细胞(PMN)比例在CFA(20±6 vs 8±2%)、RL(30±9 vs 8±2%)和ASB(12±2 vs 7±1%)中高于样本I (p < 0.05),但在SARC患者(3±1 vs 2±1%)和对照组(2±1 vs 2±1%)中样本I和样本II相似。在组合样本(I+II)中,PMN的绝对比例比单独样本II高8%,而淋巴细胞的绝对比例比单独样本II低8%。这些数据表明,从ILD患者的第一个50毫升BAL中回收的液体进行单独处理可以提供炎症细胞位置的信息,并提高BAL细胞计数的准确性。